In this cohort study involving 1902 patients with AF who were receiving factor Xa inhibitors and planned to undergo procedures with minimal to low bleeding risk, including endoscopy, dental procedures, or ocular surgery, the 30-day postprocedural event rates were 0.1% for major bleeding and 0% for thromboembolism. This evidence concerns the gene F10 and Thromboembolism.